205 related articles for article (PubMed ID: 18284922)
1. Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease.
Braun RJ; Zischka H
Biochim Biophys Acta; 2008 Jul; 1783(7):1418-35. PubMed ID: 18284922
[TBL] [Abstract][Full Text] [Related]
2. Rescue of growth defects of yeast cdc48 mutants by pathogenic IBMPFD-VCPs.
Takata T; Kimura Y; Ohnuma Y; Kawawaki J; Kakiyama Y; Tanaka K; Kakizuka A
J Struct Biol; 2012 Aug; 179(2):93-103. PubMed ID: 22728077
[TBL] [Abstract][Full Text] [Related]
3. Crucial mitochondrial impairment upon CDC48 mutation in apoptotic yeast.
Braun RJ; Zischka H; Madeo F; Eisenberg T; Wissing S; Büttner S; Engelhardt SM; Büringer D; Ueffing M
J Biol Chem; 2006 Sep; 281(35):25757-67. PubMed ID: 16822868
[TBL] [Abstract][Full Text] [Related]
4. Create and preserve: proteostasis in development and aging is governed by Cdc48/p97/VCP.
Franz A; Ackermann L; Hoppe T
Biochim Biophys Acta; 2014 Jan; 1843(1):205-15. PubMed ID: 23583830
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in p97/VCP/Cdc48 cellular functions.
Yamanaka K; Sasagawa Y; Ogura T
Biochim Biophys Acta; 2012 Jan; 1823(1):130-7. PubMed ID: 21781992
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
[TBL] [Abstract][Full Text] [Related]
7. VCP/Cdc48 rescues the growth defect of a GPI10 mutant in yeast.
Ohnuma Y; Takata T; Kawawaki J; Yasuda K; Tanaka K; Kimura Y; Kakizuka A
FEBS Lett; 2015 Feb; 589(5):576-80. PubMed ID: 25625920
[TBL] [Abstract][Full Text] [Related]
8. Roles of Cdc48 in regulated protein degradation in yeast.
Buchberger A
Subcell Biochem; 2013; 66():195-222. PubMed ID: 23479442
[TBL] [Abstract][Full Text] [Related]
9. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
Weihl CC; Dalal S; Pestronk A; Hanson PI
Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
[TBL] [Abstract][Full Text] [Related]
10. Mutant valosin-containing protein causes a novel type of frontotemporal dementia.
Schröder R; Watts GD; Mehta SG; Evert BO; Broich P; Fliessbach K; Pauls K; Hans VH; Kimonis V; Thal DR
Ann Neurol; 2005 Mar; 57(3):457-61. PubMed ID: 15732117
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of apoptosis in yeast.
Owsianowski E; Walter D; Fahrenkrog B
Biochim Biophys Acta; 2008 Jul; 1783(7):1303-10. PubMed ID: 18406356
[TBL] [Abstract][Full Text] [Related]
12. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.
Gitcho MA; Strider J; Carter D; Taylor-Reinwald L; Forman MS; Goate AM; Cairns NJ
J Biol Chem; 2009 May; 284(18):12384-98. PubMed ID: 19237541
[TBL] [Abstract][Full Text] [Related]
13. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder.
Kimonis VE; Fulchiero E; Vesa J; Watts G
Biochim Biophys Acta; 2008 Dec; 1782(12):744-8. PubMed ID: 18845250
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.
Nalbandian A; Llewellyn KJ; Gomez A; Walker N; Su H; Dunnigan A; Chwa M; Vesa J; Kenney MC; Kimonis VE
Mitochondrion; 2015 May; 22():1-8. PubMed ID: 25724235
[TBL] [Abstract][Full Text] [Related]
15. UBXD1 is a VCP-interacting protein that is involved in ER-associated degradation.
Nagahama M; Ohnishi M; Kawate Y; Matsui T; Miyake H; Yuasa K; Tani K; Tagaya M; Tsuji A
Biochem Biophys Res Commun; 2009 May; 382(2):303-8. PubMed ID: 19275885
[TBL] [Abstract][Full Text] [Related]
16. ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif.
Noguchi M; Takata T; Kimura Y; Manno A; Murakami K; Koike M; Ohizumi H; Hori S; Kakizuka A
J Biol Chem; 2005 Dec; 280(50):41332-41. PubMed ID: 16234241
[TBL] [Abstract][Full Text] [Related]
17. Doa1 is a Cdc48 adapter that possesses a novel ubiquitin binding domain.
Mullally JE; Chernova T; Wilkinson KD
Mol Cell Biol; 2006 Feb; 26(3):822-30. PubMed ID: 16428438
[TBL] [Abstract][Full Text] [Related]
18. Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy.
Guinto JB; Ritson GP; Taylor JP; Forman MS
Acta Neuropathol; 2007 Jul; 114(1):55-61. PubMed ID: 17457594
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of a drosophila IBMPFD model reveals potential pathogenic mechanisms.
Chan HT; Lee TR; Huang SH; Lee HY; Sang TK; Chan HL; Lyu PC
Mol Biosyst; 2012 Jun; 8(6):1730-41. PubMed ID: 22481368
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
Weihl CC; Miller SE; Hanson PI; Pestronk A
Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
